Special note on the occupation of Blue Sail Medical Co.Ltd(002382) non operating funds and other related capital transactions December 31, 2021
About Blue Sail Medical Co.Ltd(002382)
Special instructions on the occupation of non operating funds and other related capital transactions
Ernst & Young Huaming (2022) ZZ No. 61519262j01 Blue Sail Medical Co.Ltd(002382) Blue Sail Medical Co.Ltd(002382) board of directors:
We have audited the financial statements of Blue Sail Medical Co.Ltd(002382) in 2021, including the consolidated and company’s balance sheet on December 31, 2021, the consolidated and company’s profit statement, statement of changes in shareholders’ equity, cash flow statement and notes to relevant financial statements in 2021, and issued an unqualified audit report numbered Ernst & Young Huaming (2022) Shen Zi No. 61519262j01 on April 12, 2022.
In accordance with the requirements of the guidelines for the supervision of listed companies No. 8 – regulatory requirements for capital transactions and external guarantees of listed companies, Blue Sail Medical Co.Ltd(002382) prepared the attached summary statement of non operating capital occupation and other related capital transactions in 2021 (hereinafter referred to as the “summary statement”).
It is the responsibility of Blue Sail Medical Co.Ltd(002382) to truthfully prepare and disclose the summary and ensure its authenticity, legitimacy and integrity. We have checked the information contained in the summary sheet with the accounting information reviewed during our audit of the financial statements of Blue Sail Medical Co.Ltd(002382) 2021 and the relevant contents of the audited financial statements, and found no inconsistency in all major aspects. Except for the audit procedures for issuing the audit report on the financial statements of Blue Sail Medical Co.Ltd(002382) 2021, we did not perform additional audit procedures on the information contained in the summary.
In order to better understand the occupation of non operating funds and other related capital transactions in Blue Sail Medical Co.Ltd(002382) 2021, the summary statement should be read together with the audited financial statements.
This special instruction is only used by Blue Sail Medical Co.Ltd(002382) for the disclosure of 2021 annual report and is not applicable to other purposes.
About Blue Sail Medical Co.Ltd(002382)
Special description on occupation of non operating funds and other related capital transactions (Continued)
Ernst & Young Huaming (2022) ZZ No. 61519262j01 Blue Sail Medical Co.Ltd(002382) (no text on this page)
Ernst & Young Huaming Certified Public Accountants (special general partnership) Chinese certified public accountant: Li Huihua
Chinese certified public accountant: Gao Jie
Beijing, China April 12, 2022
Annex I Blue Sail Medical Co.Ltd(002382)
Summary of capital occupation by controlling shareholders and other related parties in 2021
Prepared by: Blue Sail Medical Co.Ltd(002382) unit: RMB 10000
Capital occupation of Listed Companies in the beginning of 2021 the year 2021 the year 2021 the year 2021 from the end of 2021
Type of fund occupier name of fund occupier the cumulative amount of current capital transactions between the occupier and the listed company also occurred in the original balance of current capital transactions caused by exchange rate changes
The amount change caused by the amount of the account balance of the related relationship is due to the nature of the transaction
Controlling shareholders and their subsidiaries
Other receivables from controlling shareholders of Zibo lanfan Investment Co., Ltd. – 317.71 (317.71) — non operating transactions of performance compensation
Biosensors International
Other receivables of group, Ltd. wholly owned subsidiary 10176368136719 (132024) (1021883) 9159180 loan non operating transactions
Biosensors Interventional
Other receivables of technologies Pte Ltd. wholly owned subsidiary 1831244 233.81 (233.57) (793.06) 1751962 loan non operating transactions
Other receivables of wholly-owned subsidiary of Zibo lanfan protective articles Co., Ltd. 4650001391568 (340768) – 1515800 loan non operating transactions
Other receivables of the wholly-owned subsidiary of the listed company Shandong Jiwei Medical Products Co., Ltd. 2522250525100 (1866350) – 1181000 investment transfer funds non operating transactions
Other receivables of the wholly-owned subsidiary of Hubei lanfan nursing supplies Co., Ltd. of 16 Shenzhen Properties & Resources Development (Group) Ltd(000011) 70 Henan Kedi Dairy Co.Ltd(002770) 00 loan non operating transactions
Other receivables of its subsidiary, Shandong Baisheng Medical Equipment Co., Ltd. – (0.09) — non operating loan transactions
Enterprise Bosheng medical equipment (Shenzhen) Co., Ltd. holding subsidiary other receivables 0.16 – (0.16) — Loan non operating transactions
Other receivables of wholly-owned subsidiary of Zibo lanfan Boxin Medical Technology Co., Ltd. – 301500 (301500) – Loan non operating transactions
Other receivables of wholly-owned subsidiary of lanfan (Shanghai) Trading Co., Ltd. – 26.04 (26.04) — Loan non operating transactions
Other receivables of wholly-owned subsidiary of Shandong lanfan new materials Co., Ltd. – 271907 (271907) — Loan non operating transactions
Other receivables of wholly-owned subsidiary of Shandong lanfan Health Technology Co., Ltd. – 35.11 (35.11) — Loan non operating transactions
Other receivables of wholly-owned subsidiary of Hangzhou lanfan Health Technology Co., Ltd. – 209.95 (209.95) — Loan non operating transactions
Annex I Blue Sail Medical Co.Ltd(002382)
Summary of capital occupation by controlling shareholders and other related parties in 2021 (Continued)
(no text on this page)
This form was approved by the board of directors on April 12, 2022.
Legal representative: Liu Wenjing financial principal: Sun Chuanzhi
Annex II Blue Sail Medical Co.Ltd(002382)
Guarantee provided to the controlling shareholder and the enterprise to which the controlling shareholder belongs
As of December 31, 2021, Blue Sail Medical Co.Ltd(002382) and its subsidiaries have not provided guarantees to the controlling shareholders and their affiliated enterprises.
This information was approved by the board of directors on April 12, 2022.
Legal representative: Liu Wenjing financial principal: Sun Chuanzhi
